Terms: = Brain cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
9 results:
1. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.
Zhu Z; Liu Y; Xu H; Ning H; Xia Y; Shen L
J Cardiothorac Surg; 2023 Aug; 18(1):254. PubMed ID: 37653509
[TBL] [Abstract] [Full Text] [Related]
2. Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
Massimino M; Vennarini S; Buttarelli FR; Antonelli M; Colombo F; Minasi S; Pecori E; Ferroli P; Giussani C; Schiariti M; Schiavello E; Biassoni V; Erbetta A; Chiapparini L; Nigro O; Boschetti L; Gianno F; Miele E; Modena P; De Cecco L; Pollo B; Barretta F
J Neurooncol; 2023 Jul; 163(3):577-586. PubMed ID: 37326761
[TBL] [Abstract] [Full Text] [Related]
3. Expression of brain‑specific angiogenesis inhibitor‑1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma.
Tian D; Hu H; Sun Y; Tang Y; Lei M; Liu L; Han R; Wu C
Mol Med Rep; 2015 Sep; 12(3):4522-4529. PubMed ID: 26129954
[TBL] [Abstract] [Full Text] [Related]
4. Gene signatures associated with mouse postnatal hindbrain neural stem cells and medulloblastoma cancer stem cells identify novel molecular mediators and predict human medulloblastoma molecular classification.
Corno D; Pala M; Cominelli M; Cipelletti B; Leto K; Croci L; Barili V; Brandalise F; Melzi R; Di Gregorio A; Sergi LS; Politi LS; Piemonti L; Bulfone A; Rossi P; Rossi F; Consalez GG; Poliani PL; Galli R
Cancer Discov; 2012 Jun; 2(6):554-68. PubMed ID: 22628409
[TBL] [Abstract] [Full Text] [Related]
5. Surveillance for renal cell carcinoma: why and how? When and how often?
Klatte T; Lam JS; Shuch B; Belldegrun AS; Pantuck AJ
Urol Oncol; 2008; 26(5):550-4. PubMed ID: 18774472
[TBL] [Abstract] [Full Text] [Related]
6. Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma.
Wavre A; Baur AS; Betz M; Mühlematter D; Jotterand M; Zaman K; Ketterer N
Neuro Oncol; 2007 Jul; 9(3):370-2. PubMed ID: 17522337
[TBL] [Abstract] [Full Text] [Related]
7. Predicting the sites of metastases from lung cancer using molecular biologic markers.
D'Amico TA; Aloia TA; Moore MB; Conlon DH; Herndon JE; Kinch MS; Harpole DH
Ann Thorac Surg; 2001 Oct; 72(4):1144-8. PubMed ID: 11603427
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic implications of chromosome 17p deletions in human medulloblastomas.
Batra SK; McLendon RE; Koo JS; Castelino-Prabhu S; Fuchs HE; Krischer JP; Friedman HS; Bigner DD; Bigner SH
J Neurooncol; 1995; 24(1):39-45. PubMed ID: 8523074
[TBL] [Abstract] [Full Text] [Related]
9. Molecular approach to rapid assessment of p53 tumor suppressor mutations in esophageal tumors from stained histological slides.
Whetsell LH; Ringer DP; Schaefer FV
Diagn Mol Pathol; 1994 Jun; 3(2):132-41. PubMed ID: 7520333
[TBL] [Abstract] [Full Text] [Related]
